InvestorsHub Logo
Followers 49
Posts 3878
Boards Moderated 0
Alias Born 09/14/2007

Re: None

Tuesday, 02/13/2018 11:10:42 AM

Tuesday, February 13, 2018 11:10:42 AM

Post# of 124
As we all know, the antibiotic drugs/companies like PRTK etc, have been ignored, or beaten for a while now, but the tide is starting to turn. The threat of antibiotic resistance is growing, and new drugs to help slow it down or potentially stop it, will be at a premium. Look, for example, 12 hours ago, a new class of "dirt" antibiotics, was discovered. Look at the big publicity for it:

http://www.bbc.com/news/health-43032602

The "dirt" antibiotics are a long way from human testing and potential approval. So what new antibiotic, the first one likely to be approved in 10 years, later this year, will be coveted by the press and by investors????

PRTK, is a rare opportunity to buy in to a company that is in an arena that has been overlooked, and quite frankly, sold off to oblivion. Now is the time to load up and hold. That's what I have done fwiw.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PRTK News